An exhibitor shows inactive COVID-19 vaccine candidates from China National Biotech Group Sinf Synopharm Group during the 2020 China International Fair for Trade in Service at the Beijing Olympic Park on September 5, 2020 in Beijing, China. Han Hayden | China News Service | Getty Images DUBAI, UAE – Human …
Read More »Get the Covid-19 vaccine first? Hospitals spittle assess how shots can be diverted
Hospitals are scrambling for plans to determine if health care workers can receive the Covid-19 vaccine first, with the expectation of an initial supply of the amount needed to vaccinate all high-priority employees. Enough is expected to deliver the December vaccine to about 200 million people, according to federal officials. …
Read More »The Covid-19 vaccine faces public concerns over rollout safety
Governments are moving toward approving the first vaccines to contain Covid-19, but public concerns about dosage safety are threatening to undermine those efforts. A survey by the University of Hamburg found that about 40% of respondents in seven European countries were hesitant or unwilling to prepare for the Covid-19 vaccine …
Read More »Gene editing shows promise in sickle-cell disease
Drug development for sickle-cell disease, largely neglected for decades, is becoming a crowded field: two papers published on Saturday in the New England Journal of Medicine give promising results from a study of experimental therapies, including Crisper gene editing for the disease. In addition, Beam Therapeutics Inc. The American Society …
Read More »Britain seeks to allay AstraZeneca’s concerns, CEO cancels trial of new vaccine
A man passes a sign at the Ast Strazeneca site in Castlesfield, McLeans, Central England. Phil Noble | Reuters LONDON – Government ministers and experts in Britain have openly endorsed the coronavirus vaccine from AstraZeneca and Oxford University, following this week’s U.S. Home Secretary Robert Genrick became the latest in …
Read More »